You Searched For "Oxford vaccine phase III trial" and got 20 results
Sort By:
1 min read
In what could be a big breakthrough in medical science, researchers at the University of Oxford start phase-1 trial of a novel HIV vaccine
The goal of the trial is to evaluate the safety, tolerability and immunogenicity of the HIVconsv…
2 mins read
Oxford’s COVID-19 vaccine: Phase III human trials begin in India
Serum Institute is likely to conduct the Phase III trials on 1,500 volunteers across 14 locati…
2 mins read
AstraZeneca's COVID-19 vaccine enters Phase-III trial in the US
The Covid-19 vaccine candidate developed by Oxford University in partnership with the UK-based g…
1 min read
DCGI permits to conduct the third phase trials of Sputnik V COVID-19 vaccine in India
The nod comes after a recent study published in the medical journal The Lancet said that Sputnik…
2 mins read
India COVID-19 vaccine tracker — Oxford’s phase III trial and Bharat Biotech, Zydus Cadila’s phase II trial results likely in November
India is witnessing a downward trend in new COVID-19 infections daily — and has managed to record 6…
2 mins read
COVID-19 vaccine latest updates: Astrazeneca’s manufacturing ‘error’ raises concerns on vaccine efficacy, Covaxin to begin phase III trials in Gujarat
The latest wave of COVID-19 infections across the world has taken the global tally of cases over th…
2 mins read
Covaxin COVID-19 vaccine's Phase III trial doesn't have enough takers, which could delay its roll out to the masses
The rollout of the Covid-19 vaccine by Bharat Biotech for the general public may get delayed as the…
2 mins read
Researchers at the University of Oxford start first human trials of Ebola vaccine
The trial will be conducted on 26 volunteers, aged between 18 and 55 years, to determine the saf…
3 mins read
Coronavirus vaccine Covishield completes enrolment of phase-3 clinical trials under ICMR, Serum Institute's partnership
"The partnership is a stellar example of private-public institutes collaborating to mitigate the…
PTI
3 mins read
Oxford-Astrazeneca COVID-19 Vaccine: Phase II trials will begin in India today
"To start with we have identified five volunteers who will undergo COVID-19 and antibodies tests…
2 mins read
Oxford researchers are seeking volunteers willing to get COVID-19 deliberately for a human challenge trial
Britain is the first country to conduct a human challenge trial, exposing people to a low dose of t…
Andrea Michelson
1 min read
Covid-19: Phase II trial of Oxford vaccine begins
New Delhi, Aug 26 (IANS) The Phase II clinical trial of the Oxford Covid-19 vaccine, Covishield, be…
2 mins read
Here's an indicative timeline for the Oxford vaccine — from phase-3 trials to the final supply in the market
SII, the world’s largest vaccine manufacturer, earlier in April, partnered with the University o…
1 min read
Phase-III trial of Sinopharm's Covid-19 vaccine starts in Abu Dhabi
The first Phase-III clinical trial of Chinese state-owned pharmaceutical company Sinopharm's inacti…
3 mins read
Chinese COVID-19 vaccine candidate produces immune response in phase 2 trial
A phase 2 trial of a Covid-19 vaccine candidate conducted in China has found that the vaccine i…
4 mins read
Oxford-Astra Zeneca COVID-19 vaccine rollout begins in the UK — 82 year-old dialysis patient first to receive the dose
Brian Pinker is among the first to be vaccinated by the Oxford University Hospital's (OUH) chie…
PTI
1 min read
Covaxin vaccine update: Bharat Biotech brings on board 13,000 volunteers for Phase III trials across multiple sites in India
The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000…
2 mins read
Canada has enough COVID-19 vaccine doses to cover each citizen five times over while the fate of 67 poor countries remains undecided
As the pharmaceutical companies around the world are locked in a race to develop a vaccine for the …
1 min read
BI India Bureau
3 mins read
The world can’t wait for good news from Oxford, Serum Institute and AstraZeneca — but that is only the first step
There is a lot of buzz around the coronavirus vaccine under trial at the University of Oxford. Re…